Linda S. Lennox
Public Communications Contact bei LANTHEUS HOLDINGS, INC.
Aktive Positionen von Linda S. Lennox
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LANTHEUS HOLDINGS, INC. | Personalreferent | 01.08.2020 | - |
Public Communications Contact | 01.08.2020 | - |
Karriereverlauf von Linda S. Lennox
Ehemalige bekannte Positionen von Linda S. Lennox
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AMAG PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.04.2015 | 01.07.2020 |
Public Communications Contact | 01.04.2015 | 01.07.2020 | |
Critical Therapeutics, Inc. | Public Communications Contact | - | 04.11.2008 |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Investor Relations Kontakt | 01.11.2010 | - |
Ausbildung von Linda S. Lennox
University of Vermont | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Public Communications Contact | 3 |
Investor Relations Contact | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LANTHEUS HOLDINGS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Critical Therapeutics, Inc. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Linda S. Lennox
- Erfahrung